parthenolide and mocetinostat

parthenolide has been researched along with mocetinostat in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheong, JW; Eom, JI; Jeung, HK; Kim, JS; Kim, SJ; Kim, YR; Min, YH1
Gan, HT; Huang, XL; Liu, L; Xiang, JY; Zhao, ZJ1

Other Studies

2 other study(ies) available for parthenolide and mocetinostat

ArticleYear
Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line, Tumor; Flow Cytometry; Glutathione; Humans; Leukemia, Myeloid, Acute; Membrane Potential, Mitochondrial; Mice; Mice, Inbred Strains; Neoplastic Stem Cells; Peroxidase; Reactive Oxygen Species; RNA, Small Interfering; Sesquiterpenes; Transfection; Xenograft Model Antitumor Assays

2010
Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates dextran sulfate sodium-induced colitis in mice.
    International immunopharmacology, 2012, Volume: 12, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; I-kappa B Proteins; Male; Mice; Mice, Inbred BALB C; NF-kappa B; NF-KappaB Inhibitor alpha; Peroxidase; Sesquiterpenes

2012